Company intelligence / Profile preview

MindTension

Kibbutz Nir Am, Southern District, Israelmindtension.com ↗

Ownership: Private
Development stage: Preclinical

Overview

MindTension has developed a patented, EMG-based medical device and advanced algorithms that objectively analyze brainstem responses to auditory stimuli. This enables accurate, reflexive diagnosis and monitoring of ADHD, with ongoing U.S. clinical trials at Mount Sinai. The technology is under FDA review for its first product focused on ADHD diagnosis and treatment optimization. Early results suggest the tool can rapidly quantify attention levels and optimize stimulant dosing in-office[2][1].

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceDigital health platform (EMG-based diagnostic system)
Industry: Physiological Monitoring

Partnerships

Mount Sinai Hospital/Health System – major U.S. clinical trial site

Beyond the preview

Go deeper on MindTension.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MindTension.

Explore the full profile